Analgesics (Pharmacies) - Niger | Statista Market Forecast

Revenue in the Analgesics market is projected to reach US$5.10m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.69%, resulting in a market volume of US$6.73m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$0.18 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Niger is experiencing steady growth due to increasing customer preferences for over-the-counter pain relief medications, along with several local special circumstances and underlying macroeconomic factors. Customer preferences in the Analgesics (Pharmacies) market in Niger are primarily driven by the convenience and availability of over-the-counter pain relief medications. Customers in Niger prefer to purchase analgesics from pharmacies due to the professional advice provided by pharmacists and the assurance of quality products. Additionally, the affordability of these medications compared to prescription drugs makes them a popular choice among consumers. Trends in the market indicate a growing demand for analgesics in Niger. This can be attributed to the increasing prevalence of chronic pain conditions, such as arthritis and migraines, among the population. The rising awareness about the importance of self-care and pain management has also contributed to the growth of the market. Furthermore, the expansion of pharmacy chains and the establishment of new pharmacies in urban areas have improved accessibility to analgesics, further driving market growth. Local special circumstances in Niger, such as the lack of access to healthcare facilities in remote areas, have led to an increased reliance on pharmacies for basic healthcare needs. Pharmacies often serve as the first point of contact for individuals seeking medical advice or treatment. This has resulted in a higher demand for analgesics, as they are readily available and can provide immediate relief for common pain ailments. Underlying macroeconomic factors, such as population growth and urbanization, have also contributed to the development of the Analgesics (Pharmacies) market in Niger. The country's growing population, coupled with the increasing urbanization rate, has created a larger consumer base for analgesics. Additionally, the improving economic conditions in Niger have led to higher disposable incomes, allowing individuals to prioritize their health and well-being, including the purchase of analgesics. In conclusion, the Analgesics (Pharmacies) market in Niger is experiencing growth due to customer preferences for over-the-counter pain relief medications, increasing prevalence of chronic pain conditions, and the convenience and accessibility provided by pharmacies. The local special circumstances of limited access to healthcare facilities and the reliance on pharmacies for basic healthcare needs further contribute to the market's development. Additionally, underlying macroeconomic factors such as population growth, urbanization, and improving economic conditions play a significant role in driving the growth of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.